Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tejpar

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Acta Gastro-Enterologica Belgica|July 15, 2005
Risk stratification for colorectal cancer and implications for screeningS Tejpar
International Journal of Immunopharmacology|January 1, 1983
Diet and immunocompetenceR K Chandra, S Tejpar
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Molecular defects in colorectal tumorigenesisS Tejpar, E van Cutsem
Acta Gastro-Enterologica Belgica|October 30, 2001
The molecular basis of colorectal cancerS Tejpar, J J Cassiman, E Van Cutsem
Acta Gastro-Enterologica Belgica|September 1, 1995
Screening for colorectal cancerE Van Cutsem, S Tejpar, P Rutgeerts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trialD Klingbiel, Z Saridaki, A D Roth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)H Piessevaux, M Buyse, W De Roock, et al.
Acta Gastro-Enterologica Belgica|April 19, 2005
Analysis of Wnt/Beta catenin signalling in desmoid tumorsS Tejpar, G Michils, H Denys, et al.
Familial Cancer|June 1, 2006
Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patientsM Spaepen, B Vankeirsbilck, S Van Opstal, et al.
British Journal of Cancer|September 2, 2015
KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?Z Saridaki, X Saegart, V De Vriendt, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Acta Gastro-Enterologica Belgica|July 15, 2005
Risk stratification for colorectal cancer and implications for screeningS Tejpar
International Journal of Immunopharmacology|January 1, 1983
Diet and immunocompetenceR K Chandra, S Tejpar
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Molecular defects in colorectal tumorigenesisS Tejpar, E van Cutsem
Acta Gastro-Enterologica Belgica|October 30, 2001
The molecular basis of colorectal cancerS Tejpar, J J Cassiman, E Van Cutsem
Acta Gastro-Enterologica Belgica|September 1, 1995
Screening for colorectal cancerE Van Cutsem, S Tejpar, P Rutgeerts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trialD Klingbiel, Z Saridaki, A D Roth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)H Piessevaux, M Buyse, W De Roock, et al.
Acta Gastro-Enterologica Belgica|April 19, 2005
Analysis of Wnt/Beta catenin signalling in desmoid tumorsS Tejpar, G Michils, H Denys, et al.
Familial Cancer|June 1, 2006
Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patientsM Spaepen, B Vankeirsbilck, S Van Opstal, et al.
British Journal of Cancer|September 2, 2015
KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?Z Saridaki, X Saegart, V De Vriendt, et al.
Pageof 5